Palvella Therapeutics, Inc. Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2017-11-13: Form 10-Q; Exhibit 10.2; Description Stock Option Agreement, dated August 9, 2017, between Pieris Pharmaceuticals Inc. and Allan Reine,.M.D..
- 2017-08-11: Form 10-Q; Exhibit 10.5; Description Employment Agreement by and between Pieris Pharmaceuticals, Inc. and Allan Reine, dated as of August 9, 2017..
- 2017-08-11: Form 10-Q; Exhibit 10.4; Description FIRST AMENDMENT TO THE.
- 2017-08-11: Form 10-Q; Exhibit 10.3; Description AMENDMENT 1.
| Filed | Form | Exhibit | Description |
|---|
| 2017-11-13 | 10-Q | 10.2 | Stock Option Agreement, dated August 9, 2017, between Pieris Pharmaceuticals Inc. and Allan Reine,.M.D. |
|---|
| 2017-08-11 | 10-Q | 10.5 | Employment Agreement by and between Pieris Pharmaceuticals, Inc. and Allan Reine, dated as of August 9, 2017. |
|---|
| 2017-08-11 | 10-Q | 10.4 | FIRST AMENDMENT TO THE |
|---|
| 2017-08-11 | 10-Q | 10.3 | AMENDMENT 1 |
|---|
| 2017-08-11 | 10-Q | 10.2 | NON-EXCLUSIVE ANTICALIN® PLATFORM TECHNOLOGY LICENSE AGREEMENT |
|---|
| 2017-08-11 | 10-Q | 10.1 | LICENSE & COLLABORATION AGREEMENT BY AND BETWEEN |
|---|
| 2017-05-15 | 10-Q | 10.3 | EXCLUSIVE OPTION AGREEMENT |
|---|
| 2017-03-30 | 10-K | 10.30 | Non-Employee Director Compensation Plan, as amended |
|---|
| 2017-03-30 | 10-K | 10.29 | Consulting Agreement by and between the Registrant and Danforth Advisors, LLC, dated as of February 1, 2017 |
|---|
| 2017-03-30 | 10-K | 10.28 | Employment Agreement by and between the Registrant and Claude Knopf, dated of November 14, 2016 |
|---|
| 2017-03-30 | 10-K | 10.26 | Separation Agreement by and between the Registrant and Darlene Deptula-Hicks, dated as of February 7, 2017 |
|---|
| 2017-03-30 | 10-K | 10.16 | Non-Exclusive Anticalin Platform Technology License Agreement Agreement by and among the Registrant, Pieris Pharmaceuticals GmbH, Les Laboratoires Servier and Institut de Recherches Internationales Servier, dated as of January 4, 2017 |
|---|
| 2017-03-30 | 10-K | 10.15 | Collaboration Agreement by and among the Registrant, Pieris Pharmaceuticals GmbH, Les Laboratoires Servier and Institut de Recherches Internationales Servier, dated as of January 4, 2017 |
|---|
| 2017-03-30 | 10-K | 10.14 | Amendment No.1 to Definitive License and Transfer Agreement by and between the Company and Enumeral Biomedical Holdings, Inc. effective as of January 3, 2017 |
|---|
| 2017-03-30 | 10-K | 10.4 | Form of Stock Option Award Agreement under the Registrant’s 2016 Employee, Director and Consultant Equity Incentive Plan |
|---|